Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Glenmark Pharm Glenmark Pharma Ltd. | BSE 2021.00 34.25 (1.72%) | NSE 2015.90 30.30 (1.53%) | Trade | Add

BSE Live

Jan 30, 16:01

2021.00 34.25 (1.72%)

Volume

AVERAGE VOLUME

5-Day

18,760

10-Day

16,880

30-Day

15,759

12,564

Prev. Close

1986.75
Open Price

1975.05

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 30, 15:57

2015.90 30.30 (1.53%)

Volume

AVERAGE VOLUME

5-Day

459,451

10-Day

421,766

30-Day

542,631

554,016

Prev. Close

1985.60
Open Price

1978.70

Bid Price (Qty.)
2015.90 (586)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Balance Sheet of Glenmark Pharma (in Rs. Cr.)	Mar 15	Mar 14	Mar 13	Mar 12	Mar 11
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	27.13	27.12	27.09	27.05	27.03
Total Share Capital	27.13	27.12	27.09	27.05	27.03
Reserves and Surplus	2,973.21	2,956.16	2,735.94	1,598.96	1,238.12
Total Reserves and Surplus	2,973.21	2,956.16	2,735.94	1,598.96	1,238.12
Total Shareholders Funds	3,000.34	2,983.28	2,763.03	1,629.54	1,265.15
Minority Interest	-0.19	13.28	24.36	25.00	26.70
NON-CURRENT LIABILITIES
Long Term Borrowings	2,574.38	2,428.66	1,920.30	1,312.47	617.07
Deferred Tax Liabilities [Net]	279.77	207.08	176.84	150.03	147.63
Other Long Term Liabilities	121.92	52.13	106.00	77.98	3.18
Long Term Provisions	0.00	0.00	0.00	14.58	6.90
Total Non-Current Liabilities	2,976.07	2,687.88	2,203.13	1,555.06	774.78
CURRENT LIABILITIES
Short Term Borrowings	347.60	838.31	367.82	687.46	1,480.23
Trade Payables	2,045.67	1,362.58	1,045.55	788.83	657.41
Other Current Liabilities	1,259.34	488.32	754.80	414.83	109.80
Short Term Provisions	58.68	259.95	12.31	10.63	11.62
Total Current Liabilities	3,711.29	2,949.17	2,180.49	1,901.74	2,259.06
Total Capital And Liabilities	9,687.51	8,633.60	7,171.00	5,883.43	5,097.78
ASSETS
NON-CURRENT ASSETS
Tangible Assets	2,056.95	1,762.81	1,554.64	1,299.45	1,179.41
Intangible Assets	1,213.49	1,272.88	1,213.57	1,125.31	972.34
Capital Work-In-Progress	0.00	0.00	0.00	0.00	0.00
Fixed Assets	3,270.44	3,035.69	2,768.21	2,424.76	2,151.75
Non-Current Investments	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets [Net]	973.06	721.30	557.10	417.42	255.77
Long Term Loans And Advances	36.50	33.06	32.33	29.81	28.13
Other Non-Current Assets	26.26	20.66	3.72	0.00	0.00
Total Non-Current Assets	4,364.23	3,870.91	3,421.72	2,932.85	2,496.21
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	0.00
Inventories	1,269.04	932.88	843.53	787.67	807.01
Trade Receivables	2,511.77	2,156.34	1,640.05	1,243.61	1,130.81
Cash And Cash Equivalents	768.14	800.67	607.31	325.35	198.63
Short Term Loans And Advances	10.77	16.84	0.00	0.00	0.00
OtherCurrentAssets	763.56	855.96	658.39	593.96	465.11
Total Current Assets	5,323.27	4,762.69	3,749.28	2,950.58	2,601.57
Total Assets	9,687.51	8,633.60	7,171.00	5,883.43	5,097.78
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	455.41	129.44	117.88	160.24	221.01
BONUS DETAILS
Bonus Equity Share Capital	15.84	15.84	15.84	15.84	15.84
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Non-Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	0.00
CURRENT INVESTMENTS
Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	0.00